EVH: Evolent Health, Inc.
About
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Current Value
$11.871 Year Return
Current Value
$11.871 Year Return
Key Details
Market Cap
$1.39B
P/E Ratio
-13.09
1Y Stock Return
-58.46%
1Y Revenue Growth
37.65%
Dividend Yield
0.00%
Price to Book
1.3
Strategies that include EVH
Stock's related to EVH
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AKAM | 60.06% | $13.12B | -22.78% | 0.00% |
| DOCS | 49.38% | $9.62B | +114.35% | 0.00% |
| ADEA | 49.37% | $1.20B | +17.45% | 1.74% |
| ASTH | 49.23% | $2.01B | +24.82% | 0.00% |
| GDOT | 48.72% | $573.37M | +28.74% | 0.00% |
| G | 48.14% | $7.83B | +31.86% | 1.34% |
| AGL | 44.27% | $655.11M | -85.55% | 0.00% |
| FLR | 43.16% | $9.03B | +40.83% | 0.00% |
| CARG | 42.19% | $3.68B | +69.13% | 0.00% |
| AMN | 41.42% | $953.75M | -62.61% | 0.00% |
| CCRN | 39.90% | $341.35M | -50.81% | 0.00% |
| FLGT | 39.49% | $519.98M | -37.82% | 0.00% |
| PRLB | 38.84% | $907.12M | +1.96% | 0.00% |
| PSEC | 38.54% | - | - | 15.48% |
| LPRO | 38.37% | $738.78M | +2.65% | 0.00% |
| DIOD | 38.22% | $2.53B | -20.36% | 0.00% |
| IOVA | 36.69% | $2.50B | +58.41% | 0.00% |
| EXPE | 36.65% | $22.72B | +30.70% | 0.00% |
| MSGE | 36.56% | $1.72B | +17.13% | 0.00% |
| GDEN | 36.39% | $910.64M | -10.03% | 2.27% |
ETF's related to EVH
News
Yahoo
We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we are going to take a look at where Evolent Health, Inc. (NYSE:EVH) stands against the other small-cap stocks. Prospects For Extended Outperformance Of Small-Cap Stocks On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief […]
SeekingAlpha
Evolent Health has seen a significant 50% drop due to a Q3 earnings miss and high medical costs. Read why I think EVH stock is a buy.
Yahoo
Evolent Health ( NYSE:EVH ) Third Quarter 2024 Results Key Financial Results Revenue: US$621.4m (up 22% from 3Q 2023...
Yahoo
As previously reported, Stephens analyst Jeff Garro downgraded Evolent Health (EVH) to Equal Weight from Overweight with a price target of $16, down from $38. Rising oncology costs are stressing Evolent’s profitability and exposing timing issues inherent to its at-risk Performance Suite business, the analyst tells investors in a research note. While the firm thinks these weaknesses can be remedied, improving contractual protections across the entire book will take time, the analyst added. Publis
SeekingAlpha
The following slide deck was published by Evolent Health, Inc.
SeekingAlpha
Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ETParticipantsSeth Blackley - Chief Executive OfficerJohn Johnson...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.